DrexlerH.G.Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma1992; 8: 283–313.
2.
ChittalS.M., CaverivièreP., SchwartingR.Monoclonal antibodies in the diagnosis of Hodgkin's disease: The search for a rational panel. Am J Surg Pathol1988; 12: 9–21.
3.
SteinH.Ki-1 anaplastic large cell lymphoma: Is it a discrete entity?Leuk Lymphoma1993; 10(Suppl): 81–4.
4.
KadinM.E.Primary Ki-1-positive anaplastic large cell lymphoma: a distinct clinicopathologic entity. Ann Oncol1994; 5(suppl 1): 25–30.
5.
CarboneA., GloghiniA., VolpeR.Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas. Virchows Arch (A) Pathol Anat1992; 420: 527–32.
6.
CarboneA., GloghiniA., VolpeR., BoiocchiM.Anti-vimentin antibody reactivity with Reed-Sternberg cells of Hodgkin's disease. Virchows Arch (A)1990; 417: 43–8.
7.
PinkusG.S., SaidJ.W.Hodgkin's disease, lymphocyte predominance type, nodular - further evidence for a B-cell derivation. L&H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol1988; 133: 211–7.
8.
PinkusG.S., ThomasP., SaidJ.W.Leu-M1 - a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol1985; 119: 244–52.
9.
CarboneA., PolettiA., ManconiR., VolpeR., BettaP.G.Reliability of anti-Leu-M1 immunostaining in Hodgkin's diseases. Arch Pathol Lab Med1986; 110: 465–6.
10.
CarboneA., ManconiR., PolettiA.Reed-Sternberg cells and their cell microenvironment in Hodgkin's disease with reference to macrophage-histiocytes and interdigitating reticulum cells. Cancer1987; 60: 2662–8.
11.
AgnarssonB.A., KadinM.E.Ki-1 positive large cell lymphoma: A morphologic and immunologic study of 19 cases. Am J Surg Pathol1988; 12: 264–74.
12.
HallP.A., D'ArdenneA.J., StansfeldA.G.Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (Ki1) lymphoma. Histopathology1988; 13: 161–9.
13.
RossoR., PaulliM., MagriniU.Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen: Immunohistochemical and morphological relationship to Hodgkin's disease. Virchows Arch (A) Pathol Anat1990; 416: 229–35.
14.
FrizzeraG.The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Sem Diagn Pathol1992; 9: 291–6.
15.
CarboneA., GloghiniA., VolpeR.Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Cancer1992; 70: 2691–8.
16.
CohenP.L., ButmarcJ., KadinM.E.Expression of Hodgkin's disease associated antigen BLA. 36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin. Am J Clin Pathol1995; 104: 50–3.
17.
MerzH., HoussiauF.A., OrscheschekK.Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood1991; 78: 1311–7.
18.
CarboneA., GloghiniA., GatteiV.Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood1995; 85: 780–9.
19.
CarboneA., CozziM., GloghiniA., PintoA.CD26/DPPIV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Hum Pathol1994; 25: 1360–5.
20.
CarboneA., GloghiniA., GrussH-J, PintoA.CD40 antigen expression on Reed-Sternberg cells. A reliable diagnostic tool for Hodgkin's disease. Am J Pathol1995; 146: 780–1.
21.
MurrayP.G., OatesJ., ReynoldsG.M., CrockerL., YoungL.S.Expression of B7 (CD80) and CD40 antigens and the CD40 ligand in Hodgkin's disease is independent of latent Epstein-Barr virus infection. J Clin Pathol Mol Pathol1995; 48: M105–8.
22.
StamenkovichI., ClarkE.A., SeedB.A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J1989; 8: 1403–10.
23.
DörkenB., MöllerP., PezzuttoA., Schwartz-AlbiezR., MoldenhauerG.B-cell antigens: CD40. In: KnappW., DörkenB., GilksW.R., RieberE.P., SchmidtR.E., SteinH., Von Dem BorneAEGKr, eds. Leucocyte typing IV. White cell differentiation antigens.Oxford: Oxford University Press, 1989; 90–1.
24.
UckunF.M., Gajl-PeczalskaK., MyersD.E., JaszczW., HaissigS., LedbetterJ.A.Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 as well as B-lineage non-Hodgkin's lymphoma cells. Blood1990; 76: 2449–56.
25.
GalyA.H.M., SpitsH.CD40 is functionally expressed on human thymic epithelial cells. J Immunol1992; 1149: 775–82.
26.
SchrieverF., FreedmanA.S., FreemanG.Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med1989; 169: 2043–58.
27.
LawC-L, WörmannB., LeBienT.W.Analysis of expression and function of CD40 on normal and leukemic human B cell precursors. Leukemia1990; 4: 732–8.
28.
ShippM.A., LookA.T.Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key!Blood1993; 82: 1052–70.
29.
CarboneA., GloghiniA., ZagonelV., PintoA.An update on the diagnostic relevance of CD26 antigen expression in CD30 positive anaplastic large cell lymphomas. Hum Pathol1995; 26: 1169–70.
30.
NishiokaY., LipskyP.The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J Immunol1994; 153: 1027–36.
31.
ArmitageR.J., MacduffB.M., SpriggsM.K., FanslowW.C.Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol1993; 150: 3671–80.
32.
LiuY-J, MasonD.Y., JohnsonG.D.Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol1991; 21: 1905–10.
33.
LedermanS., YellinM.J., InghiramiG., LeeJ.J., KnowlesD.M., ChessL.Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: Roles of T cell-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol1992; 149: 3817–36.
34.
CarboneA., GloghiniA., GrussH-J, PintoA.CD40 ligand is constitutively expressed in a subset of T-cell lymphomas and on the microenvironmental reactive T-cells of follicular lymphomas and Hodgkin's disease. Am J Pathol1995; 147: 912–22.
35.
InghiramiG., LedermanS., YellinM.J., ChadburnA., ChessL., KnowlesD.M.Phenotypic and functional characterization of T-BAM (CD40 ligand)+T-cell non-Hodgkin's lymphoma. Blood1994; 84: 866–72.
36.
CarboneA., GloghiniA., ZagonelV.Expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non Hodgkin's lymphomas/leukemias. Blood1995; 86: 4617–26.